<DOC>
	<DOCNO>NCT01678235</DOCNO>
	<brief_summary>The aim study determine whether insulin glulisine effective postprandial glycemic control insulin aspart H-GI meal child type 1 diabetes ( T1DM ) treat insulin pump ( CSII ) .</brief_summary>
	<brief_title>Insulin Glulisine Aspart Postprandial Glycemic Control After High-GI Meal Children With Type 1 Diabetes Mellitus</brief_title>
	<detailed_description>Some study suggest insulin glulisine ( GLU ) slightly faster onset action compare insulin aspart ( ASP ) . Meals high glycemic index ( H-GI ) distinct effect postprandial glycaemia ( PPG ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Type 1 diabetes mellitus CSII least 3 month Duration diabetes &gt; 1 year Informed consent Concomitant dietary restriction ( e.g . celiac disease food allergy ) Diabetes related complication Baseline hyperglycemia &gt; 150 mg/dl Any disease judge investigator affect trial</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>diabetes</keyword>
	<keyword>insulin pump</keyword>
	<keyword>glulisine</keyword>
	<keyword>aspart</keyword>
	<keyword>glycemic index</keyword>
</DOC>